サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1528032

DNAシーケンスの世界市場

DNA Sequencing

出版日
ページ情報
英文 392 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
DNAシーケンスの世界市場
出版日: 2024年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 392 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

DNAシーケンスの世界市場は2030年までに171億米ドルに達する見込み

2023年に78億米ドルと推定されるDNAシーケンスの世界市場は、2030年には171億米ドルに達し、分析期間2023-2030年のCAGRは11.8%で成長すると予測されます。DNAシーケンス消耗品は、本レポートで分析したセグメントの1つであり、CAGR 11.5%を記録し、分析期間終了時には75億米ドルに達すると予測されます。DNAシーケンス機器セグメントの成長率は、分析期間中CAGR 10.2％と推定されます。

米国市場は31億米ドルと推定、中国はCAGR 15.9％で成長予測

米国のDNAシーケンス市場は、2023年に31億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに25億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは15.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.8%と9.5%と予測されています。欧州では、ドイツがCAGR約9.0%で成長すると予測されています。

世界のDNAシーケンス市場- 主要動向と促進要因まとめ

DNAシーケンスとは何か、なぜ変革をもたらすのか？

DNAシーケンスとは、DNA分子内のヌクレオチドの正確な順序を決定するプロセスです。DNA鎖中の4つの塩基（アデニン、グアニン、シトシン、チミン）の順序を決定するために使用されるあらゆる方法や技術が含まれます。DNAの塩基配列を迅速かつ安価に決定する能力は、生物学研究において極めて重要な要素となっており、科学者は生物およびウイルスの発生、機能、繁殖を導く遺伝子の青写真を観察することができます。過去数十年の間に、DNAシーケンス技術の進歩はゲノミクスの分野に革命をもたらし、多くの疾患の遺伝的基盤、種の進化、集団間の遺伝的変異性の同定に関する深い洞察につながった。

DNAシーケンスの技術はどのように進歩したのか？

DNAシーケンスにおける技術の進歩は、サンガーシーケンスのような方法を含む第一世代シーケンスから、何百万もの小さなDNA断片のシーケンスを並行して行い、DNAシーケンスに関連する時間とコストを大幅に削減できる次世代シーケンス（NGS）への軌跡をほぼたどってきました。NGSプラットフォームは、精度、スピード、価格を向上させ、全ゲノムシーケンスや個別化ゲノミクスのような大規模プロジェクトを、より多くの研究者や臨床医にとって実現可能なものにする急速な機能強化を遂げてきました。さらに、1分子リアルタイムシーケンス技術を含む第3世代シーケンス技術の開発は、DNAサンプルの増幅を必要とせず、さらに高速で正確なシーケンス機能を提供することで、この分野にさらなる革命をもたらすことを約束しています。

DNAシーケンスの主な用途は何ですか？

DNAシーケンスのアプリケーションは多岐に渡り、様々な分野に応用されています。ヘルスケアでは、遺伝性疾患の診断、がんにつながる可能性のある変異の特定、個人の遺伝的体質に基づいた治療方針の決定に使用されています。農業分野では、DNAシーケンスは植物の遺伝子構造を正確に変化させることで、高収量で害虫に強い作物を作るのに役立っています。さらに、法医学では、シークエンシングによって、DNAの微細なサンプルから高い精度で個人を特定することができます。環境科学者は、DNAシーケンスを使って生物多様性を研究し、集団遺伝学を理解し、環境の変化が生態系の遺伝物質に及ぼす影響を追跡しています。それぞれのアプリケーションは、複雑な生物学的システムの理解と管理を進める上で、DNAシーケンスの技術が大きな影響を与えていることを示しています。

DNAシーケンス市場の成長はいくつかの要因によってもたらされる

DNAシーケンス市場の成長は、急速な技術進歩、コストの低下、さまざまな分野への応用拡大など、いくつかの要因によって牽引されています。個々の治療計画を調整するために遺伝子情報に大きく依存する精密医療の採用が増加していることは、主要な成長促進要因です。さらに、政府および民間の資金援助による世界の遺伝子研究活動の活発化は、高度なシーケンスソリューションの需要に大きく寄与しています。DNAシーケンスを利用したパーソナライズされた健康評価や家系サービスに対する関心が高まっていることから、消費者行動も市場成長に影響を与えています。さらに、COVID-19パンデミックは、ウイルス変異の特定と追跡における迅速なシーケンス技術の重要性を浮き彫りにし、世界の健康課題への対応におけるDNAシーケンスの重要な役割を浮き彫りにしました。このような要因が、DNAシーケンス市場の継続的な拡大と革新に拍車をかけ、ゲノム研究において最もダイナミックな分野の一つとなっています。

調査対象企業の例（全76件）

  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP11607

Global DNA Sequencing Market to Reach US$17.1 Billion by 2030

The global market for DNA Sequencing estimated at US$7.8 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the DNA Sequencing Instruments segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 15.9% CAGR

The DNA Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global DNA Sequencing Market - Key Trends & Drivers Summarized

What Is DNA Sequencing and Why Is It Transformative?

DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The ability to sequence DNA quickly and affordably has become a pivotal factor in biological research, enabling scientists to observe the genetic blueprint that guides the development, functioning, and reproduction of living organisms and viruses. Over the past few decades, advancements in DNA sequencing technologies have revolutionized the field of genomics, leading to profound insights into the genetic bases of many diseases, the evolution of species, and identification of genetic variability among populations.

How Has Technology Advanced in DNA Sequencing?

Technological advancements in DNA sequencing have largely followed the trajectory from first-generation sequencing, which includes methods like Sanger sequencing, to next-generation sequencing (NGS), which allows for sequencing of millions of small fragments of DNA in parallel, significantly reducing the time and cost associated with DNA sequencing. NGS platforms have undergone rapid enhancements that have increased accuracy, speed, and affordability, making large-scale projects like whole-genome sequencing and personalized genomics feasible for more researchers and clinicians. Additionally, the development of third-generation sequencing technologies, which include single-molecule real-time sequencing techniques, promises to further revolutionize the field by offering even faster and more accurate sequencing capabilities without the need for amplification of DNA samples.

What Are the Major Applications of DNA Sequencing?

The applications of DNA sequencing are extensive and varied across multiple fields. In healthcare, it is used for diagnosing genetic disorders, identifying mutations that may lead to cancer, and guiding treatment decisions based on an individual’s genetic makeup. In agriculture, DNA sequencing assists in creating high-yield, pest-resistant crops by enabling precise alterations to the genetic structure of plants. Furthermore, in forensic science, sequencing can identify individuals with high accuracy from minute samples of DNA. Environmental scientists use DNA sequencing to study biodiversity, understand population genetics, and track the effects of environmental changes on genetic material in ecosystems. Each application demonstrates the significant impact of DNA sequencing technologies in advancing our understanding and management of complex biological systems.

Growth in the DNA Sequencing Market Is Driven by Several Factors

The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing. Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.

Select Competitors (Total 76 Featured) -

  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • DNA Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction
    • A Brief History on Evolution of DNA Sequencing Technology
    • Different Types of Sequencing Approaches
    • Shotgun Sequencing
    • High-Throughput Approach
    • Long-Read Sequencing Approaches
    • Single Molecule Real Time (SMRT) Sequencing
    • Nanopore DNA Sequencing
    • Short-Read Sequencing Approaches
    • Massively Parallel Signature Sequencing (MPSS)
    • Massively Parallel Signature Sequencing (MPSS)
    • Polony Sequencing
    • 454 Pyrosequencing
    • Illumina (Solexa) Sequencing
    • Combinatorial Probe Anchor Synthesis (cPAS)
    • SOLiD sequencing
    • Ion Torrent Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Heliscope Single Molecule Sequencing
    • Microfluidic Systems
    • A Prelude to DNA Sequencing
    • Major Applications
    • DNA Sequencing Application
    • Global Market Prospects and Outlook
    • DNA Sequencing Market Set for a Rapid Growth
    • Regional Market Perspective
    • North America Leads the Global Market
    • Competition
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Next Generation Sequencing Drives the Market Growth
    • Increasing R&D Activities in NGS
    • Illumina, the Dominant Force in the Global NGS Market
    • Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth
    • Increasing Use in Drug Discovery Drives Market Growth
    • Increasing Emphasis on Personalized Medicine Drives Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rising Incidence of Cancer to Drive Market Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • DNA Sequencing and Cancer Care
    • Technological Advancements in NGFS Aids Market Expansion
    • The First Mobile Genome Sequence Analyzer in the World
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinical Investigation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Forensics & Agrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for HLA Typing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 39: World 16-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 42: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 45: World 16-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 48: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 49: World DNA Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: USA 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: China Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: China 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: UK 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of World 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION